Embryome Sciences acquired an exclusive license to
Advanced Cell Technology.
Embryome Sciences acquired an exclusive license to Advanced Cell
Technology's ACTCellerate embryonic stem cell technology and cell
lines in July.
COPYRIGHT 2008 Strategic Directions International
Inc. (SDI) Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.